Dáil Éireann Debate, Thursday - 25 June 2015
27. Deputy Clare Daly asked the Minister for Defence in view of his statements to Dáil Éireann on 9 June 2015 regarding the continued use of Lariam by the Defence Forces, if he has initiated medical advice on the matter; the medical experts he has consulted with; his plans to make their conclusions available; and if there is a timescale on their deliberations. [25090/15]
Amharc ar fhreagraAs the Deputy will be aware, the Health Products Regulatory Authority (HPRA), formerly the Irish Medicines Board is the statutory authority with responsibility for quality, safety and efficacy of medicines in Ireland. The Defence Forces policy, in relation to the use of anti-malaria medication, including Lariam, is in line with current HPRA approved summary of product characteristics (SmPC).
The health, welfare and safety of Defence Force personnel is a priority of the military authorities and of mine. Malaria is a very serious disease. It kills approximately 1 million people per year in sub-Saharan Africa alone. It is a grave threat to any military force operating in that area. The military authorities take considerable care in prescribing the best medication taking all circumstances into account. In the decade of deployment to sub-Saharan Africa by the Defence Forces, not a single member of the Defence Forces has died from malaria. The anti-malaria regime in place in the Defence Forces, including the use of Lariam, is working.
Former Ministers for Defence have had the various allegations surrounding the use of Lariam investigated thoroughly and obtained the advice of leading medical experts, who concur with the prescribing practices followed by the Defence Forces.
The choice of medication is a medical decision made by Medical Officers in the Defence Forces having regard to the specific circumstances of the mission and the individual member of the Defence Forces. That position has not changed and I have no plans at present to further investigate the use of Lariam in the Defence Forces.
Anti-malarial medications, including Lariam is licensed by the HPRA and must remain in the formulary of medications prescribed by the Medical Corps for Defence Forces personnel on appropriate overseas missions, particularly those in sub-Saharan Africa, to ensure that our military personnel can have effective protection from the very serious risks posed by this highly dangerous disease.
